Condition: Luteal Phase Deficiency · Luteal Phase Support · Idiopathic Hypogonadotropic Hypogonadism · Sponsor: Fudan University
Luteal phase deficiency (LPD) accounts for most failures of assistant artificial reproduction (ART) and early pregnancy loss for patients with idiopathic hypogonadotropic hypogonadism (IHH). Luteal phase support (LPS) is one of the indispensable interventions in ART treatments for IHH patients, which includes progestin, estrogen, human chorionic gonadotropin (hCG), and GnRH agonists (GnRHa). We aim to verify additional hCG injection 48 hours following routine hCG trigger and ovulation for LPS on the basis of supplementation of estrogen and dydrogesterone could improve clinical pregnancy rate, cumulative pregnancy rate, live birth rate and the prevalence of early pregnancy loss and ovarian hyperstimulation syndrome (OHSS) by an open labeled, prospective, and randomized clinical trial (RCT) in IHH patients in a single center.
This description comes directly from the study's public registry record.
Hexia Xia, M.D. · +86 13601843476 · hexia_xia@fudan.edu.cn
Wei Zhang, Ph.D.,M.D. · +86 13611691036 · zhangwei623@hotmail.com
Always discuss trial participation with your own doctor first.
| OB & GYN Hospital of Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
| Obstetrics and Gynecology Hospital of Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05569577